← Back to Search

Behavioral Intervention

Antenatal Obesity Treatment for Pregnancy-Related Obesity (GWG Trial)

N/A

Waitlist Available

Led By Sharon J Herring, MD, MPH

Research Sponsored by Temple University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12-month pp

Awards & highlights

GWG Trial Summary

This trial will test if an obesity treatment can help lower weight gain during pregnancy when given through the Women, Infants, and Children program in Philadelphia.

Who is the study for?

This trial is for African American or Hispanic women who are part of the Philadelphia WIC program, have a BMI ≥ 25 kg/m2, and are less than 16 weeks pregnant. They must own a cell phone with unlimited texting and be able to do light exercises like walking. Women with certain medical conditions or those who've had bariatric surgery can't join.Check my eligibility

What is being tested?

The study is testing an antenatal obesity treatment (AO) designed to manage weight gain during pregnancy. It's integrated into the Philadelphia WIC program and involves receiving texts as part of the intervention.See study design

What are the potential side effects?

Since this trial focuses on lifestyle interventions such as diet control and physical activity rather than medication, side effects may include typical exercise-related discomforts but should not involve drug-related adverse reactions.

GWG Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12-month pp

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12-month pp

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-month pp for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in maternal weight

Proportion of women with excessive gestational weight gain

Secondary outcome measures

Change in Dietary intake

Change in accelerometer-measured physical activity

Change in maternal 12-month weight postpartum (pp)

+7 more

GWG Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Antenatal Obesity Treatment (AO)Experimental Treatment1 Intervention

The AO arm consists of a multi-component, theory- and evidence-based intervention and includes weight-related behavior change through goal setting and self-monitoring, behavioral skills training, interpersonal support, and social modeling strategies.

Group II: WIC Standard Care (SC)Active Control1 Intervention

Participants assigned to the WIC standard care arm will receive usual care offered to pregnant women at WIC.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Temple UniversityLead Sponsor

296 Previous Clinical Trials

82,379 Total Patients Enrolled

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,356 Previous Clinical Trials

4,314,650 Total Patients Enrolled

Sharon J Herring, MD, MPHPrincipal InvestigatorTemple University

2 Previous Clinical Trials

694 Total Patients Enrolled

Media Library

Antenatal Obesity Treatment (AO) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03707834 — N/A

Pregnancy Research Study Groups: Antenatal Obesity Treatment (AO), WIC Standard Care (SC)

Pregnancy Clinical Trial 2023: Antenatal Obesity Treatment (AO) Highlights & Side Effects. Trial Name: NCT03707834 — N/A

Antenatal Obesity Treatment (AO) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03707834 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research program currently inviting participants to enroll?

"Clinicaltrials.gov's records indicate that this medical research is actively seeking participants, beginning with its listing on the 1st of July 2018 and then most recently updated on May 25th 2022."

Answered by AI

What is the enrollment cap for this clinical trial?

"Affirmative, information hosted on clinicaltrials.gov reveals that this research is currently in need of participants. The study was initially posted on July 1st 2018 and last modified on May 25th 2022 - it seeks to enrol 438 patients from a single medical facility."

Answered by AI

What key goals is this research attempting to achieve?

"The primary aim of this clinical trial is to measure the proportion of pregnant women who gain excessive gestational weight. Secondary goals include tracking changes in maternal postpartum weight, hypertension rates and infant length at 6 months old. Weight will be calculated using a calibrated scale while medical records are consulted for hypertension diagnoses and infants' lengths are measured at 6 months post-birth."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Partnering With WIC to Prevent Excessive Weight Gain in Pregnancy

2018. "Partnering With WIC to Prevent Excessive Weight Gain in Pregnancy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03707834.

All > Weight Gain > Overweight